178 related articles for article (PubMed ID: 31175888)
1. Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats.
Ali AA; Ahmed HI; Khaleel SA; Abu-Elfotuh K
Physiol Behav; 2019 Sep; 208():112571. PubMed ID: 31175888
[TBL] [Abstract][Full Text] [Related]
2. Early ethanol exposure and vinpocetine treatment alter learning- and memory-related proteins in the rat hippocampus and prefrontal cortex.
Swart PC; Currin CB; Russell VA; Dimatelis JJ
J Neurosci Res; 2017 May; 95(5):1204-1215. PubMed ID: 27614144
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse.
Wei Y; Liu D; Zheng Y; Li H; Hao C; Ouyang W
Brain Res Bull; 2017 Sep; 134():262-272. PubMed ID: 28867383
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
5. The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (aβ) peptide.
Shekarian M; Komaki A; Shahidi S; Sarihi A; Salehi I; Raoufi S
Behav Brain Res; 2020 Apr; 383():112512. PubMed ID: 31991177
[TBL] [Abstract][Full Text] [Related]
6. Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway.
Ahmed HI; Abdel-Sattar SA; Zaky HS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1327-1338. PubMed ID: 30083945
[TBL] [Abstract][Full Text] [Related]
7. Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats.
Fu X; Zhang J; Guo L; Xu Y; Sun L; Wang S; Feng Y; Gou L; Zhang L; Liu Y
Pharmacol Biochem Behav; 2014 Nov; 126():122-30. PubMed ID: 25220684
[TBL] [Abstract][Full Text] [Related]
8. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
9. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
10. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
11. Suppression of BACE1 and amyloidogenic/RAGE axis by sitagliptin ameliorates PTZ kindling-induced cognitive deficits in rats.
Safar MM; Shahin NN; Mohamed AF; Abdelkader NF
Chem Biol Interact; 2020 Sep; 328():109144. PubMed ID: 32653415
[TBL] [Abstract][Full Text] [Related]
12. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
13. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of ginsenoside Rg1 prevents cognitive impairment induced by isoflurane anesthesia in aged rats via antioxidant, anti-inflammatory and anti-apoptotic effects mediated by the PI3K/AKT/GSK-3β pathway.
Zhang Y; Zhang Z; Wang H; Cai N; Zhou S; Zhao Y; Chen X; Zheng S; Si Q; Zhang W
Mol Med Rep; 2016 Sep; 14(3):2778-84. PubMed ID: 27485139
[TBL] [Abstract][Full Text] [Related]
15. Supplementation of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress.
Wang J; Li L; Wang Z; Cui Y; Tan X; Yuan T; Liu Q; Liu Z; Liu X
J Nutr Biochem; 2018 Jun; 56():16-25. PubMed ID: 29454265
[TBL] [Abstract][Full Text] [Related]
16. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from
Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R
ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205
[TBL] [Abstract][Full Text] [Related]
17. Isoflurane anesthesia promotes cognitive impairment by inducing expression of β-amyloid protein-related factors in the hippocampus of aged rats.
Zhang S; Hu X; Guan W; Luan L; Li B; Tang Q; Fan H
PLoS One; 2017; 12(4):e0175654. PubMed ID: 28403230
[TBL] [Abstract][Full Text] [Related]
18. Melatonin ameliorates Aβ
Chinchalongporn V; Shukla M; Govitrapong P
J Pineal Res; 2018 May; 64(4):e12470. PubMed ID: 29352484
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1-42)-induced cognitive deficit rats.
Garabadu D; Verma J
Neurochem Int; 2019 Sep; 128():39-49. PubMed ID: 31004737
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Effect of Nanodiamond in Alzheimer's Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 Signaling.
Alawdi SH; El-Denshary ES; Safar MM; Eidi H; David MO; Abdel-Wahhab MA
Mol Neurobiol; 2017 Apr; 54(3):1906-1918. PubMed ID: 26897372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
